InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,464.00
(
0.26%
)
Dow Jones
38,675.68
(
0.00%
)
Brent Oil
83.55
(
0.51%
)
Bitcoin
64,302.46
(
0.47%
)
Post# of 1162
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Johnny_C

Send PM Follow Ignore
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Johnny_C

Re: Tonymann post# 685

Monday, 11/06/2017 10:06:20 AM

Monday, November 06, 2017 10:06:20 AM

Post# of 1162
Tony, if in fact they are a buy out play by PFE the 3rd quarter results are fantastic. Higher expenses to Eliquis was one reason for a tiny miss on earnings.

The sales increasing is the key, as synergies if a merger occurs will most likely be massive.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent BMY News
More BMY News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!